OneDraw(TM) Blood Collection Device Receives the Red Dot Award for Outstanding Medical Device Product Design
PR84498
MENLO PARK, California, June 25, 2020 /PRNewswire=KYODO JBN/ --
Drawbridge Health today announced that the OneDraw(TM) Blood Collection Device,
the enabling technology for the FDA cleared OneDraw(TM) A1C Test System, has
won the prestigious Red Dot Award: Product Design 2020(
) in the category of Medical Devices. This recognition for the OneDraw Blood
Collection Device underscores Drawbridge Health's quest to become a leading
innovator in patient-centric blood sampling.
Photo -
https://mma.prnewswire.com/media/1194999/Drawbridge_Health_OneDraw_A1C_Test_System.jpg
Logo - https://mma.prnewswire.com/media/899446/Drawbridge_Logo.jpg
In the Red Dot Award global competition, the OneDraw Blood Collection Device
was among over 6,500 products entered into the competition from more than sixty
countries. The award for Outstanding Medical Device Product Design followed
hands-on evaluation of the OneDraw Blood Collection Device by a panel of
international experts.
The OneDraw Blood Collection Device(
) uniquely enables remote sample collection anytime and anywhere in a
convenient, comfortable way and is intended to help improve patient care and
compliance. Importantly, the high quality sample is stable for up to three
weeks* and has the potential to bring lab testing into the home setting.
Instead of using a traditional hypodermic needle to puncture a patient's vein,
the device is placed on the skin and blood is gently collected using tiny
lancets with a light vacuum suction.
The Drawbridge Health team developed the OneDraw Blood Collection Device with a
focus on creating a comfortable, convenient, and effortless blood draw
experience for both patients and healthcare professionals. The device was
designed to collect blood in a "closed system," with the sample pulled directly
into the device, without visible lancets. The OneDraw Blood Collection Device
is an innovative device that significantly reduces obstacles for drawing blood
— pain and discomfort from venipuncture and fingerstick — that until now were
accepted as unavoidable.
"We are extremely proud to have the OneDraw Blood Collection Device selected as
the best-of-the-best in product design. The Red Dot Award highlights our
commitment to excellence and quality, and demonstrates our devotion to
developing a patient-centric device. OneDraw was developed with thoughtful
design and superior engineering, delivered in a simple and intuitive device
that streamlines the blood draw process and greatly improves the experience for
patients and healthcare professionals," said Lee McCracken, CEO at Drawbridge
Health.
The OneDraw A1C Test System received FDA clearance in August 2019 and completed
the CE Mark process in February 2020. The OneDraw Blood Collection Device will
be added to the Red Dot Design Museum Essen, a showcase for Red Dot Award
recipients, showcasing best-in-class product design from around the world.
About the Red Dot Design Award
In order to appraise the diversity in the field of design in a professional
manner, the Red Dot Design Award breaks down into the three disciplines of Red
Dot Award: Product Design, Red Dot Award: Brands & Communication Design and Red
Dot Award: Design Concept. With more than 18,000 entries, the Red Dot Award is
one of the world's largest design competitions. In 1955, a jury convened for
the first time to assess the best designs of the day. In the 1990s, Red Dot CEO
Professor Dr. Peter Zec developed the name and brand of the award. Ever since,
the sought-after distinction "Red Dot" has been the revered international seal
of outstanding design quality. The award winners are presented in the
yearbooks, museums and online. More information is available at www.red-dot.de.
About Drawbridge Health
Founded in 2015 by GE Ventures and GE Healthcare, Drawbridge Health is a
healthcare technology company focused on reinventing the blood draw experience,
enabling comfortable convenient blood sample collection anytime and anywhere.
By integrating engineering, chemistries, and modular design, Drawbridge is
developing a people-friendly system for collecting and stabilizing blood
samples, opening new doors to enable access to important health information.
For more information, please visit www.drawbridgehealth.com.
Contact:
Eddy Garcia
egarcia@dbhealth.com
* As shown in the OneDraw A1C Test System validation.
SOURCE: Drawbridge Health
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。